Therefore, the central ghrelin signaling system connects neurobiological circuits involved in food and chemical drug reward; substances that either directly or indirectly inhibit this system become promising candidate medications for treating substance use disorders and preventing problematic overeating that results in obesity [33,34]. Here, GHRL is linked to obesity due to melanocortin 4 receptor deficiency.